Researchers

RAI Shinya

RAI Shinya
Lecturer in Medical School
Faculty Department of Medicine
Researchmap https://researchmap.jp/srai

Education and Career

Education

  • - 2005/03 , Kindai University, Faculty of Medicine,

Academic & Professional Experience

  • Kindai University Faculty of Medicine 講師

Research Activities

Research Areas

  • Life sciences, Hematology and oncology

Published Papers

  1. Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study.
    Koji Izutsu; Kiyoshi Ando; Momoko Nishikori; Hirohiko Shibayama; Hideki Goto; Junya Kuroda; Koji Kato; Yoshitaka Imaizumi; Kisato Nosaka; Rika Sakai; Maho Abe; Seiichiro Hojo; Tadashi Nakanishi; Shinya Rai
    International journal of hematology  23, Aug. 2024 
  2. Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305).
    Shigeru Kusumoto; Wataru Munakata; Ryunosuke Machida; Takashi Terauchi; Hiroaki Onaya; Masahiko Oguchi; Shinsuke Iida; Kisato Nosaka; Yasuhiro Suzuki; Yasuhiko Harada; Kana Miyazaki; Masaki Maruta; Noriko Fukuhara; Tomomi Toubai; Nobuko Kubota; Ken Ohmachi; Toko Saito; Shinya Rai; Ishikazu Mizuno; Suguru Fukuhara; Mai Takeuchi; Ukihide Tateishi; Dai Maruyama; Kunihiro Tsukasaki; Hirokazu Nagai
    Cancer science  22, Jul. 2024 
  3. Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.
    Shinya Rai; Won Seog Kim; Kiyoshi Ando; Ilseung Choi; Koji Izutsu; Norifumi Tsukamoto; Dai Maruyama; Kunihiro Tsukasaki; Junya Kuroda; Jun Ando; Michihiro Hidaka; Youngil Koh; Hisashi Kato; Toshiki Uchida; Deok Hwan Yang; Kenji Ishitsuka; Kenichi Ishizawa; Jin Seok Kim; Hong Ghi Lee; Hironobu Minami; Hyeon Seok Eom; Mitsutoshi Kurosawa; Jae Hoon Lee; Jong Seok Lee; Won Sik Lee; Hirokazu Nagai; Takero Shindo; Dok Hyun Yoon; Shinichiro Yoshida; Mireille Gillings; Hiroshi Onogi; Kensei Tobinai
    Haematologica  6, Jun. 2024 

MORE

Books etc

  1. Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase III POLARIX trial. , 頼晋也 , 血液内科 , 血液内科 , 2024
  2. Epigenetic alterations and advancement of treatment in malignant lymphoma , 頼晋也 , 2023
  3. The role of radiation therapy in the treatment of early-stage Hodgkin lymphoma. , 頼晋也 , 2021

MORE

Conference Activities & Talks

  1. Six cases of oral solid tumor after allogeneic hematopoietic stem cell transplantation , 鳥畑さやか; 江原裕基; 助臺美帆; 下出孟史; 岩崎早苗; 李篤史; 川口美紅; 木下優子; 渡瀬遂生; 金澤仁美; 守屋実央; 安武夏海; 兵頭咲紀; 宮本あかね; 谷口康博; 頼晋也; 榎本明史; 濱田傑; 芦田隆司; 芦田隆司 , 日本造血細胞移植学会総会プログラム・抄録集 , 2021
  2. Gilteritinib treatment for extramedullary relapse of FLT3-ITD acute myeloid leukemia , 口分田貴裕; 頼晋也; 波江野高大; 角谷宏明; 源周治; 綿谷陽作; 芹澤憲太郎; 谷口康博; 森田泰慶; 田中宏和; 芦田隆司; 松村到 , 日本造血細胞移植学会総会プログラム・抄録集 , 2021
  3. Clinical usefulness of Letermovir for patients with stem cell transplantation , 谷口康博; 平瀬主税; 芦田隆司; 波江野高大; 角谷宏明; 源周治; 綿谷陽作; 口分田貴裕; 芹澤憲太郎; 頼晋也; 森田泰慶; 田中宏和; 辰巳陽一; 松村到 , 日本造血細胞移植学会総会プログラム・抄録集 , 2021

MORE

MISC

  1. Pembrolizumab as a salvage therapy for patients with refractory or relapse primary mediastinal large B-cell lymphoma. , 井上宏昭; 頼晋也 , 月刊血液内科 , 81 , 2 , 2020
  2. 脳静脈洞血栓症を合併し、開頭減圧術・術後エクリズマブ投与が有効であったPNHの一例(Post-operative treatment with eculizumab for PNH presenting as cerebral venous sinus thrombosis) , 岩田 吉生; 森田 泰慶; 辻 潔; 頼 晋也; 田崎 貴之; 井上 宏昭; 谷口 康博; 藤本 昂; 田中 宏和; 芦田 隆司; 加藤 天美; 松村 到 , 臨床血液 , 59 , 9 , 1765 , 1765 , Sep. 2018
  3. 腹水貯留にて発症したprimary effusion lymphoma-like diffuse large B-cell lymphomaの1例 , 堀川 亮太; 頼 晋也; 齋藤 花往里; 森田 泰慶; 田中 宏和; 辰巳 陽一; 芦田 隆司; 松村 到 , 臨床血液 , 58 , 1 , 48 , 48 , Jan. 2017

MORE

Patents

  1. 受容体の細胞内輸送制御による白血病治療のための新規医薬組成物 , 頼 晋也, 田中 宏和, 松村 到, 渡邊 利雄

Research Grants & Projects

  1. 日本学術振興会, 科学研究費助成事業 基盤研究(C), 多発性骨髄腫の病態形成に関わる抗腫瘍免疫機構の解析研究 , 近畿大学
  2. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Characterization molecular and immunologic features of CML stem cells for treatment-free remission. , Kindai University
  3. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Analysis of novel pathogenesis caused by disorder of immature hematopoietic cells in multiple myeloma , Kindai University

MORE